IN8bio, Inc. (INAB) Dividend History
IN8bio, Inc. (INAB) is a clinical-stage biotechnology company focused on developing innovative cell therapies for the treatment of resistant and hard-to-treat cancers. The company leverages its proprietary gamma delta T cell platform to engineer and enhance immune responses against tumors, aiming to improve patient outcomes through its advanced immunotherapy approaches.
Dividend History
IN8bio, Inc. currently does not pay dividends